India, Feb. 10 -- Santhera Pharmaceuticals Holding AG (SPHDF.OB, 0QN1.L) Monday announced that it has appointed Catherine Isted as Chief Financial Officer, with effect from February 24.
Isted succeeds Andrew Smith, who will be stepping down after 5 years of service at the Swiss specialty pharmaceutical company. Smith will remain to support the transition in the upcoming months.
Most recently, Isted served as CFO at BenevolentAI and previously worked at ReNeuron Group plc and Oxford Biomedica plc.
According to the firm, Isted, with over 25 years of leadership experience, is suited to support Santhera's continued commercial expansion and next phase of growth.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digita...